Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines

Anti-Cancer Drugs

Volumn 8, Issue 6, 1997, Pages 623-631

  Buquet Fagot, Christine ^a   Lallemand, François ^a   Montagne, Marie Noëlle ^a   Mester, Jan ^a  

^a INSERM   (France)

Author keywords

Cdk; Cell cycle; Nucleoside transport; Olomoucine; pRb

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; OLOMOUCINE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CELL CYCLE; CELL DIVISION; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; HUMANS; KINETIN; LOVASTATIN; NEOPLASMS; PURINES; RETINOBLASTOMA PROTEIN; THYMIDINE; THYMIDINE KINASE; TRITIUM; TUMOR CELLS, CULTURED;

EID: 0030798355     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199707000-00011     Document Type: Article

References (17)

1. Vesely J, Havlicek L, Strnad M, et al. Inhibition of cyclin-dependent kinases by purine derivatives. Eur J Biochem 1994; 224: 771-86.
2. Abraham RT, Acquarone M, Andersen A, et al. Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. Biol Cell 1995; 83: 105-20.
3. Fang F, Newport JW. Evidence that G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell 1991; 66: 731-42.
4. Pagano M, Pepperkok P, Lukas J. et al. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 1993; 121: 101-11.
5. Riahowol K, Draetta G, Brizuela L, Vandre DD, Beach D. The cdc2 kinase is a nuclear protein that is essential tor mitosis in mammalian cells. Cell 1989; 57: 393-401.
6. Sherr CJ. The ins and outs of RB: coupling gene expression to the cell cycle clock. Trends Cell Biol. 1994; 4: 15-8.
7. Weinberg RA. The retinoblastoma protein and the cell cycle control. Cell 1995; 81: 323-30.
8. 1 to multiple cell cycles by lovastatin. Cancer Res 1991; 51: 3602-10.
9. Forgue-Lafitte ME, Coudray AM, Fagot D, Mester J. Effects of ketoconazole on the proliferation and cell cycle of human cancer cell lines. Cancer Res 1992; 52: 6827-31.
10. 2 arrest. Mol Cell Biol 1993; 13: 6640-52.
11. 2+ for the induction of thymidine kinase but not ornithine decarboxylase in 3T3 cells stimulated from quiescence. Biochem J 1990; 272: 525-7.
12. Chen P-L, Scully P, Shew J-Y, Wang JY, Lee W-H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58: 1193-8.
13. Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097-105.
14. Mittnacht S, Lees JA, Desai D, Harlow E, Morgan DO, Weinberg R. Distinct sub-populations of the retioblastoma protein show a distinct pattern of phosphorylation. EMBO J 1994; 13: 118-27.
15. van den Heuvel S, Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 1993; 262: 2050-4.
16. Ongkeko W, Ferguson DJP, Harris AL, Norbury C. Inactivation of Cdc2 increases the level of apoptosis induced by DNA damage. J Cell Sci 1995; 108: 2897-904.
17. Belt AJ, Marina NM, Phelps DA, Crawford CR. Nucleoside transport in normal and neoplasmic cells. Adv Enzyme Reg 1993; 33: 235-52.